LDLR and Hyperglycemia: In summary, our findings suggest that hyperglycemia and glucose intolerance caused by the SUR1-E1506K mutation in LDLR-/- mice promote a vulnerable plaque phenotype, which is possibly due to increased vascular inflammation and NLRP3 inflammasome activation.